Skip to Main content Skip to Navigation

Biomarkers for the prognosis and high-grade glioma clinical outcome

Abstract : The present invention relates to the identification and use of biomarkers with clinical relevance to high grade gliomas (HGGs). In particular, the invention provides the identity of four genes, CHAF1B, PDLIM4, EDNRB and HJURP, whose expression, at the transcriptome and proteome levels, is correlated with HGG grading and clinical survival outcome. Methods and kits are provided for using these biomarkers in the prognostication of HGGs, and in the selection and/or monitoring of treatment regimens.
Document type :
Complete list of metadata
Contributor : Laurent Jonchère <>
Submitted on : Monday, February 16, 2015 - 1:48:31 PM
Last modification on : Thursday, January 14, 2021 - 11:15:46 AM


  • HAL Id : hal-01117079, version 1


Jean Mosser, Marie De Tayrac, Marc Aubry. Biomarkers for the prognosis and high-grade glioma clinical outcome. United States, Patent n° : 20120129711. 2012. ⟨hal-01117079⟩



Record views